As an investor, when the company making the pitch says “We are a Class I, II and III device!” your ears should perk up immediately, because that is just not right. And never correct.
In this third clip from my RAQA Today conversation with Mitch Robbins, I share my experiences listening to investor pitches and discuss what the company making the pitch should – and should not – tell you.
Investor Seed Money
Biotech is one of the riskiest sectors to invest in, so potential investors need to be able to discern signals
Learn More
What Investors Need to Know About Start-Ups
Startups have different challenges along the road to market release than do the larger, established medical device organizations. As an
Learn More
So You Want to be a Regulatory Consultant?
Then you will want to check out my interview with Elena Kyria on the Career Diaries podcast. We discussed the details
Learn More
Michelle Lott and the leanTeam help clients recognize regulatory and quality issues aren't a "burden" – they are strategic advantages when used properly. The expert team will also strip away any redundant or misdirected activities so you can focus on what really matters:
